Major bone, muscle and joint congress to include focus on sarcopenia and frailty

November 23, 2015

Nyon, Switzerland - November 23, 2015 Clinicians, researchers and leading musculoskeletal diseases experts from more than 60 countries will attend the much anticipated 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

As in past years, this annual event is expected to showcase more than 800 original research abstracts from across the field's clinical spectrum. Renowned global experts will lead a wide variety of sessions on the most current advances in research and clinical practice, including in the emerging fields of sarcopenia and frailty.

Professor Jean-Yves Reginster, Congress Co-chair and President of the European Society for Clinical and Economic Aspects of Osteoporosis & Osteoarthritis (ESCEO), stated, "Given the growth in the ageing population worldwide, it is vital that we increase our knowledge of age-related muscle loss, bone and muscle strength, and their respective roles in maintaining function and mobility. The prevention and treatment of sarcopenia and frailty - which affect balance, falls and fracture risk as well as the overall ability to perform tasks of daily living - are therefore an important new focus of the annual WCO-IOF-ESCEO congresses."

The Congress programme will feature 10 Plenary Lectures, 5 Special Lectures, 15 Meet-the-Expert Sessions, 4 ESCEO Symposia, 15 Non-Sponsored Symposia, and 4 Industry-Sponsored Symposia. In addition, oral presentations of selected noteworthy abstracts will showcase the latest 'hot' new research.

WCO-IOF-ESCEO 2016 has been granted 15 European CME credits by the European Accreditation Council for Continuing Medical Education (EACCME). EACCME credits can be converted to AMA credits.

> Complete meeting information is available at http://www.wco-iof-esceo.org/

"The Scientific Programme Committee has prepared a high-quality programme which presents exciting new research findings and the latest advances of relevance to clinical practice. The Congress offers an ideal opportunity to network with renowned experts and clinicians from around the world. And, as the largest and one of the mostly highly regarded clinical meetings in the world, it is a forum of choice for the presentation of new research findings," added Professor John A. Kanis, Congress Co-chair and President of the International Osteoporosis Foundation (IOF).

> Abstracts, which will appear in a supplement issue of the leading journal 'Osteoporosis International', are accepted until the deadline of January 15, 2016.

To be held in Malaga, a major and easily accessible seaside city in southern Spain, the Congress is expected to attract more than 3200 delegates. Delegates will include endocrinologists, rheumatologists, orthopaedists, geriatricians, radiologists, internists, general practitioners, rehabilitation specialists and other allied health professionals.

> Delegates registering online before December 4, 2015 benefit from early-bird registration rates. To register online visit http://www.wco-iof-esceo.org/register
-end-
About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 230 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

About ESCEO

The European Society for Clinical & Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.